Abstract

CD38 is an ADP-ribosyl cyclase, producing a potent Ca(2+) mobilizer cyclic ADP-ribose (cADPR). In this study, we have investigated a role of CD38 and its regulation through interleukin-8 (IL8) signaling in lymphokine-activated killer (LAK) cells. Incubation of LAK cells with IL8 resulted in an increase of cellular cADPR level and a rapid rise of intracellular Ca(2+) concentration ([Ca(2+)](i)), which was sustained for a long period of time (>10 min). Preincubation of an antagonistic cADPR analog, 8-Br-cADPR (8-bromo-cyclic adenosine diphosphate ribose), abolished the sustained Ca(2+) signal only but not the initial Ca(2+) rise. An inositol 1,4,5-trisphosphate (IP(3)) receptor antagonist blocked both Ca(2+) signals. Interestingly, the sustained Ca(2+) rise was not observed in the absence of extracellular Ca(2+). Functional CD38-null (CD38(-)) LAK cells showed the initial rapid increase of [Ca(2+)](i) but not the sustained Ca(2+) rise in response to IL8 treatment. An increase of cellular cADPR level by cGMP analog, 8-pCPT-cGMP (8-(4-chlorophenylthio)-guanosine-3',5'-cyclic monophosphate), but not cAMP analog or phorbol 12-myristate 13-acetate was observed. IL8 treatment resulted in the increase of cGMP level that was inhibited by the IP(3) receptor blocker but not a protein kinase C inhibitor. cGMP-mediated Ca(2+) rise was blocked by 8-Br-cADPR. In addition, IL8-mediated LAK cell migration was inhibited by 8-Br-cADPR and a protein kinase G inhibitor. Consistent with these observations, IL8-induced migration of CD38(-) LAK cells was not observed. However, direct application of cADPR or 8-pCPT-cGMP stimulated migration of CD38(-) cells. These results demonstrate that CD38 is stimulated by sequential activation of IL8 receptor, IP(3)-mediated Ca(2+) rise, and cGMP/protein kinase G and that CD38 plays an essential role in IL8-induced migration of LAK cells.

Highlights

  • CD38 is an ADP-ribosyl cyclase, producing a potent Ca2؉ mobilizer cyclic ADP-ribose

  • Direct application of cyclic ADP-ribose (cADPR) or 8-pCPT-cGMP stimulated migration of CD38؊ cells. These results demonstrate that CD38 is stimulated by sequential activation of IL8 receptor, IP3-mediated Ca2؉ rise, and cGMP/protein kinase G and that CD38 plays an essential role in IL8-induced migration of lymphokineactivated killer (LAK) cells

  • The results indicate that CD38 is activated via phate; 8-Br-cADPR, 8-bromo-cADPR; 8-pCPT-cGMP, 8-(4-chlorophenylthio)-guanosine-3Ј,5Ј-cyclic monophosphate; Rp-8-pCPT-cGMPS, 8-(4-chlorophenylthio)-guanosine-3Ј,5Ј-cyclic monophosphorothioate, Rp-isomer; IL, interleukin; IL8 receptor (IL8R), interleukin 8 receptor; IP3, inositol 1,4,5-trisphosphate; IP3R, IP3 receptor; LAK, lymphokine-activated killer; ␤-NADϩ, ␤-nicotinamide adenine dinucleotide; NGD, nicotinamide guanine nucleotide; PKG, protein kinase G; RyR, ryanodine receptor; PLC, phospholipase C; BSA, bovine serum albumin; HPLC, high performance liquid chromatography

Read more

Summary

Killer Cells*

Direct application of cADPR or 8-pCPT-cGMP stimulated migration of CD38؊ cells These results demonstrate that CD38 is stimulated by sequential activation of IL8 receptor, IP3-mediated Ca2؉ rise, and cGMP/protein kinase G and that CD38 plays an essential role in IL8-induced migration of LAK cells. The results indicate that CD38 is activated via phate; 8-Br-cADPR, 8-bromo-cADPR; 8-pCPT-cGMP, 8-(4-chlorophenylthio)-guanosine-3Ј,5Ј-cyclic monophosphate; Rp-8-pCPT-cGMPS, 8-(4-chlorophenylthio)-guanosine-3Ј,5Ј-cyclic monophosphorothioate, Rp-isomer; IL, interleukin; IL8R, interleukin 8 receptor; IP3, inositol 1,4,5-trisphosphate; IP3R, IP3 receptor; LAK, lymphokine-activated killer; ␤-NADϩ, ␤-nicotinamide adenine dinucleotide; NGD, nicotinamide guanine nucleotide; PKG, protein kinase G; RyR, ryanodine receptor; PLC, phospholipase C; BSA, bovine serum albumin; HPLC, high performance liquid chromatography. CGMP/protein kinase G (PKG) that is activated by IL8 and that CD38 plays a critical role in IL8-mediated Ca2ϩ signal and migration of LAK cells

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call